// App-Quantinova.ai

: Use of Serum Antiopoietin-2 Assay for Therapeutic Decision-Making in Patients with Vascular Anomalies

Researchers

Presenter

  • Elissa Engel

Principal Investigators

  • Kiersten Ricci

  • Adrienne M Hammill

  • Karen Mittermeier

  • Timothy D. LeCras

  • Lori Luchtman-Jones

Medical Centers

  • Division of Hematology, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

  • Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

Disease

  • Acute respiratory failure

  • Thrombocytopenia

  • Hematology-oncology disease

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • D-dimer

Drug/Treatment

  • Methylprednisolone

  • Zoledronic acid

  • Vincristine

  • Fibrinogen (IV)

  • Trametinib

  • Celecoxib

  • ALT-210

  • sirolimus

  • Rapacan

Outcome

  • N/A

Study Design

  • Efficacy

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved